Who
Larry Lee Miller
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Phibro Animal Health.
In numbers
- Trades disclosed
- 141
- Buys
- 0
- Sells
- 39
- Bought
- $0
- Sold
- $18.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Apr 2014
- Last trade
- 6 Aug 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 17 Sep 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,726 at $0.00 | filing |
| 6 Aug 2026filed 17 Sep 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,726 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,522 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,522 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $23K635 at $36.60 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $23K635 at $36.60 | filing |
| 15 Aug 2025filed 19 Aug 2025 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —5,184 at $0.00 | filing |
| 5 Jul 2023filed 7 Jul 2023 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 9 Feb 2021filed 10 Feb 2021 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $459K20,000 at $22.94 | filing |
| 8 Feb 2021filed 10 Feb 2021 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —250,000 at $0.00 | filing |
| 8 Feb 2021filed 10 Feb 2021 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | —50,000 | filing |
| 7 May 2018filed 7 May 2018 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 14 Feb 2018filed 15 Feb 2018 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —17,928 at $0.00 | filing |
| 14 Feb 2018filed 15 Feb 2018 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | $212K17,928 at $11.83 | filing |
| 14 Feb 2018filed 15 Feb 2018 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $631K17,928 at $35.19 | filing |
| 13 Feb 2018filed 13 Feb 2018 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —22,086 at $0.00 | filing |
| 13 Feb 2018filed 13 Feb 2018 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | $261K22,086 at $11.83 | filing |
| 13 Feb 2018filed 13 Feb 2018 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $774K22,086 at $35.05 | filing |
| 12 Feb 2018filed 13 Feb 2018 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —18,304 at $0.00 | filing |
| 12 Feb 2018filed 13 Feb 2018 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | $211K17,804 at $11.83 | filing |
News
MediciNova (NASDAQ:MNOV) & Phibro Animal Health (NASDAQ:PAHC) Head to Head ComparisonPAHC · themarketsdaily.com · 14 Oct 2026Contrasting Phibro Animal Health (NASDAQ:PAHC) and Tvardi Therapeutics (NASDAQ:TVRD)PAHC · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Larry Lee Miller; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.